ABSTRACTS Archives - Page 45 of 107

O.1 A new frailty scoring in ‘clinically fit’ older patients with malignant hemopathies admitted to receive chemotherapy

BJH - volume 8, issue Abstract Book BHS, february 2017

S. Dubruille PhD, C. Kenis , Y. Libert PhD, M. Delforge MD, PhD, J. Alexis Ruiz , M. Roos , A. Collard , N. Meuleman MD, PhD, M. Maerevoet MD, D. Razavi MD, PhD, H. Wildiers , D. Bron MD, PhD

O.2 A single analysis for simultaneous measurement of all 4 DOACs

BJH - volume 8, issue Abstract Book BHS, february 2017

J. Emmerechts MD, PhD, S. Ameye , V. Engelrelst , D. Borrey

O.3 Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an attractive Novel Drug Target in Multiple Myeloma and its associated Bone Disease

BJH - volume 8, issue Abstract Book BHS, february 2017

R. Heusschen PhD, A. Bolomsky , K. Schlangen , K. Schönfelder , J. Muller MSc, W. Schreiner , N. Zojer , J. Caers MD, PhD, H. Ludwig

O.4 In vitro generation of tumor antigen-specific T cells from patient and healthy donor stem cells

BJH - volume 8, issue Abstract Book BHS, february 2017

S. Bonte PhD, S. Snauwaert MD, PhD, G. Goetgeluk , B. Vandekerckhove MD, PhD, T. Kerre MD, PhD

O.5 Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): an interim analysis from the Belgian Hematology Society (BHS)

BJH - volume 8, issue Abstract Book BHS, february 2017

X. Poiré MD, PhD, C. Graux MD, PhD, A. Ory , J. Jamart , F. Frédéric , H. Schoemans MD, PhD, P. Lewalle MD, PhD, A. De Becker MD, D. Deeren MD, Z. Berneman MD, PhD, T. Kerre MD, PhD, P. Zachée MD, PhD, D. Selleslag MD, Y. Beguin MD, PhD

O.6 Successful Transition from paediatric to adult care in Sickle Cell Disease: An Experience in a Belgian Center

BJH - volume 8, issue Abstract Book BHS, february 2017

T. Vandergraesen

PP01 Mucosal- associated invariant T cells deficiency in multiple myeloma can be overcome by PD-1 inhibition

BJH - volume 8, issue Abstract Book BHS, february 2017

M. Favreau , K. Venken , S. Faict , dr. K. Maes , K. De Veirman , E. De Bruyne , X. Leleu , D. Elewaut , K. Vanderkerken PhD, E. Menu